AI Article Synopsis

  • Microcirculatory dysfunction is linked to poor outcomes in both septic and cardiogenic shock, but its prognostic value in cardiogenic shock patients on VA-ECMO is not well understood.
  • A study analyzed microcirculation in 48 patients at various time points after VA-ECMO, comparing outcomes of 28-day nonsurvivors and survivors based on parameters like perfused small vessel density (PSVD) and proportion of perfused vessels (PPV).
  • Results indicate that lower PSVD and PPV are associated with worse survival, suggesting that early microcirculatory assessment could help predict outcomes in these patients.*

Article Abstract

Background: Microcirculatory dysfunction develops in both septic and cardiogenic shock patients, and it is associated with poor prognosis in patients with septic shock. Information on the association between microcirculatory dysfunction and prognosis in cardiogenic shock patients with venoarterial extracorporeal membrane oxygenation (VA-ECMO) support is limited.

Methods: Sublingual microcirculation images were recorded using an incident dark-field video microscope at the following time points: within 12 h (T1), 24 h (T2), 48 h (T3), 72 h (T4), and 96 h (T5) after VA-ECMO placement. If a patient could be weaned off VA-ECMO, sublingual microcirculation images were recorded before and after VA-ECMO removal. Microcirculatory parameters were compared between 28-day nonsurvivors and survivors with VA-ECMO support. In addition, the microcirculation and clinical parameters were assessed as prognostic tests of 28-day mortality, and patients were divided into three subgroups according to microcirculation parameters for survival analysis.

Results: Forty-eight patients were enrolled in this study. At T1, the observed heart rate, mean arterial pressure, inotropic score and lactate level of 28-day nonsurvivors and survivors did not differ significantly, but the perfused small vessel density (PSVD) and proportion of perfused vessels (PPV) were lower in the 28-day nonsurvivors than in the survivors. The PSVD and PPV were slightly superior to lactate levels in predicting 28-day mortality (area under curve of 0.68, 0.70, and 0.62, respectively). The subgroup with the lowest PSVD (< 15 mm/mm) and PPV (< 64%) values exhibited less favorable survival compared with the other two subgroups.

Conclusions: Early microcirculatory parameters could be used to predict the survival of cardiogenic shock patients with VA-ECMO support.

Trial Registration: ClinicalTrials.gov, NCT02393274 . Registered on 19 March 2015.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098836PMC
http://dx.doi.org/10.1186/s13054-018-2081-2DOI Listing

Publication Analysis

Top Keywords

28-day nonsurvivors
12
nonsurvivors survivors
12
patients venoarterial
8
venoarterial extracorporeal
8
extracorporeal membrane
8
membrane oxygenation
8
microcirculatory dysfunction
8
cardiogenic shock
8
shock patients
8
va-ecmo support
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!